Retrospective review of exceptions for angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker recommendations for a diabetic medicare population

Chanadda Chinthammit, Amanda Harrington, Ann Wild, Shepin Werner, Kevin Boesen, Ann M. Taylor, Terri L. Warholak

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)358-365b
JournalJournal of Managed Care and Specialty Pharmacy
Volume25
Issue number3
DOIs
StatePublished - Mar 1 2019
Externally publishedYes

ASJC Scopus Subject Areas

  • Pharmacy
  • Pharmaceutical Science
  • Health Policy

Cite this